BioSpace News Archive

Drug Development

Ophthotech Announces First Patient Enrolled in the Phase IIb Clinical Trial of Zimura, Complement C5 Inhibitor, for the Treatment of Autosomal Recessive Stargardt Disease (STGD1)

Ophthotech announced today that the first patient has been enrolled in the Phase 2b randomized, double-masked, sham-controlled clinical trial assessing the efficacy and safety of Zimura (avacincaptad pegol), complement C5 inhibitor, in patients with autosomal recessive Stargardt disease (STGD1).

January 16, 2018
·
6 min read
Tenax Therapeutics Announces Plan to Develop Levosimendan for a Pulmonary Hypertension Indication with No FDA Approved Therapies

Tenax announced plans to advance the development of levosimendan for the treatment of Pulmonary Hypertension associated with Heart Failure and preserved Ejection Fraction (PH-HFpEF).

January 16, 2018
·
4 min read
Business

CompleWare and YPrime Announce Partnership Agreement

CompleWare and YPrime announce a partnership agreement to deliver enhanced service offerings involving clinical trials, eCOA technology and IRT.

January 16, 2018
·
2 min read
Business

Spyryx Biosciences Expands with Election of Roger Jeffs, PhD as Independent Director

Dr. Jeffs brings over 25 years of biopharmaceutical industry experience, including 18 years at United Therapeutics where he retired in 2016 as President and Co-CEO.

January 16, 2018
·
2 min read
Biotech Bay

GigaGen Receives NIH Grant to Develop Production Technology for Recombinant Intravenous Immunoglobulin

GigaGen will use the funds to develop a natural repertoire antibody protein expression system.

January 16, 2018
·
3 min read
Business

Geoffrey B. Davis Joins GT Biopharma’s Board of Directors

Mr. Davis is the founding partner of Barker Davis, a law firm focused on Life Sciences transactions, and formerly a partner at Ropes & Gray, where he played a significant role in establishing the firm’s internationally recognized Life Sciences group.

January 16, 2018
·
4 min read
Drug Development

RedHill Biopharma Announces Final Results From Phase II Study With BEKINDA for IBS-D

The company confirmed that the Phase II study with BEKINDA 12 mg successfully met its primary endpoint.

January 16, 2018
·
8 min read
Gyros Protein Technologies Introduces Multi-Species Kit for Toxicokinetic Studies

The new Gyrolab Generic TK Kit adds to a growing menu of ready-to-use kits, and allows researchers to more efficiently quantify human therapeutic antibodies (IgG) in automated, nanoliter-scale Gyrolab xP and Gyrolab xPlore systems.

January 16, 2018
·
2 min read
Arbutus Announces Closing of the Second Tranche of a $116M Strategic Investment From Roivant Sciences

The Tranche 2 closing represents the second of two tranches of Preferred Shares issued to Roivant.

January 16, 2018
·
2 min read
Antibiotic Resistance: Pherecydes Pharma Raises €8.7M ($10.3M)

With this financial support, the company plans to produce phages for compassionate use in accordance with GMP.

January 16, 2018
·
9 min read